CXCL16 and prostate carcinoma: Mechanistically, TGFβR2-negative prostate CAFs were found to increase CXCL1, CXCL16 and CXCL5 expression and facilitate prostate cancer cell adhesion to bone COL1 fibers to promote skeletal metastasis in C4-2B xenografts [156].